Stock ATOS ATOSSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Atossa Therapeutics, Inc.

Equities

ATOS

US04962H5063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.53 USD +0.66% Intraday chart for Atossa Therapeutics, Inc. +11.68% +73.86%
Apr. 15 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Announces I-SPY 2 Clinical Trial to Evaluate (Z-Endoxifen in Combination with Abemaciclib (VERZENIO®?) in Women with ER+/HER2- Breast Cancer CI
Apr. 09 Atossa Therapeutics, Inc. Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Atossa Therapeutics, Inc., Q2 2023 Earnings Call, Aug 14, 2023
Transcript : Atossa Therapeutics, Inc. - Special Call
Transcript : Atossa Therapeutics, Inc. - Special Call
Transcript : Atossa Therapeutics, Inc. - Special Call
Transcript : Atossa Therapeutics, Inc. Presents at LD Micro 500 Virtual Investor Conference, Sep-04-2020 09:00 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATOS Stock
  4. News Atossa Therapeutics, Inc.
  5. Transcripts